David Mott is an investment management professional specializing in family office management, estate and generational wealth planning, and tax strategy. They currently serve as the Chief Executive Officer and Chief Investment Officer at Sphinx Mountain Capital and as Chairman at Mersana Therapeutics and Adaptimmune, among several other roles in various organizations. With over 30 years of experience in the biopharmaceutical industry, Mott has been involved in more than $40 billion in fundraising and has led or participated in over 35 IPOs. Mott holds a Bachelor’s Degree in Economics and Government from Dartmouth College and has served on numerous for-profit and not-for-profit boards throughout their career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices